Refresh

Kappac Pharma Ltd. - Research Center

506938 KAPPH Group (XC) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 20 Mar ' 18 Mar ' 17 Mar ' 16 Mar ' 15
Income

Operating income

- - - - -
Expenses

Material consumed

- - - - -

Manufacturing expenses

- - - - -

Personnel expenses

0.01 - - - -

Selling expenses

- - - - -

Adminstrative expenses

- 0.01 0.04 0.02 0.05

Expenses capitalised

- - - - -

Cost of sales

0.02 0.01 0.04 0.02 0.05

Operating profit

- - -0.04 -0.02 -0.05

Other recurring income

- - - - -

Adjusted PBDIT

- - - - -

Financial expenses

- - - - -

Depreciation

- - - - 0.03

Other write offs

- - - - -

Adjusted PBT

-0.02 -0.01 -0.04 -0.02 -0.08

Tax charges

- - - - -

Adjusted PAT

- - - - -

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

-0.02 -0.01 -0.04 -0.02 -0.08

Earnigs before appropriation

-0.02 -0.01 -1.28 -1.24 -1.22

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-0.02 -0.01 -1.28 -1.24 -1.22
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com